Vascular Graft Market Size To Report Impressive Growth, Revenue To Surge To USD 3,571.32 Million by 2032
Currently synthetic vascular graft materials are used in order to patch the diseased area of the arteries. Vascular grafts can be used in arteries, capillaries or veins. There was a negative impact of the pandemic on vascular graft market as the supply chain distribution system and operations were all halted, there were cancellations or postpones in all of these procedures as the healthcare professionals across the globe are focusing on COVID-19 treatment and all the non essential surgeries were declined.
Vascular graft market study was worth around USD 1958.98 Million in 2023 and is predicted to grow to around USD 3,571.32 Million by 2032 with a compound annual growth rate (CAGR) of roughly 6.90% between 2024 and 2032
Growth Factors
The increase in the number of chronic kidney diseases and dialysis procedure has led to a growth in the market about a couple of million people take treatment for dialysis across the world so it happens to drive the market for vascular grafts. Increase in the cardiovascular diseases renal diseases and diabetes are driving the market for the vascular grafts. Across the world many deaths occur due to the cardiovascular diseases across many nations. Surgeries related to the heart involve the use of vascular grafts and hence the market is expected to grow during the forecast.
Citing an instance, in September 2018, LeMaitre Vascular Incorporation declared that it acquired vascular clot management business from Applied Medical Resources Corporation at US$ 14.2 million. Both the firms also signed a transition services agreement as per which the latter will continue to produce the product for LeMaitre for nearly one year.
As estimated in this report, the global vascular graft market stood at US$ 2.31 billion in 2024. Witnessing a tremendous rise during the period from 2023 to 2032, the revenue in this vascular graft market is expected to reach US$ 3.48 billion by the end of the forecast period. The main products available in this vascular graft market are hemodialysis access graft, endovascular stent graft, peripheral vascular, and coronary artery bypass graft. Among the four, the demand for endovascular stent graft is relatively higher and the trend is anticipated to remain so over the next few years, notes the research report.
Prominent Use Of Minimally Invasive Implants To Drive Market Growth
“Escalating demand for minimally invasive implants along with rising incidences of deaths occurring as a result of cardiac arrests is likely to drive the growth of vascular graft market in the years ahead,” says the author of this study. Apart from this, the growing occurrence of diabetes along with stimulated demand for technologically advanced products for treating vascular ailments will spur the vascular graft market size in the years ahead. In addition, extensive product applications in hospitals and ambulatory surgical centers will further enhance the scope of vascular graft market in the near future.
Key aspects of the vascular graft market include:
Types of Vascular Grafts:
Synthetic Grafts: Synthetic vascular grafts are made from materials such as expanded polytetrafluoroethylene (ePTFE), polyester (Dacron), or polyurethane. They are commonly used in bypass surgeries for peripheral arterial disease, aortic aneurysms, and hemodialysis access.Biologic Grafts: Biologic vascular grafts are derived from human or animal tissues, such as veins (autologous or allogeneic), arteries (xenografts), or pericardium. They are used in procedures such as coronary artery bypass grafting (CABG), peripheral artery bypass, and arteriovenous fistula creation for hemodialysis.Hybrid Grafts: Hybrid vascular grafts combine synthetic and biologic materials to improve biocompatibility, durability, and long-term patency. These grafts may incorporate a synthetic scaffold with a biologic lining or coating to promote endothelialization and reduce thrombogenicity.
Market Growth Drivers:
Aging Population: The aging global population, coupled with lifestyle factors such as smoking, obesity, and diabetes, contributes to the increasing incidence of vascular diseases such as peripheral artery disease (PAD), coronary artery disease (CAD), and aortic aneurysms, driving demand for vascular grafts.Technological Advancements: Advances in graft materials, manufacturing techniques, and surgical instrumentation have led to the development of innovative vascular grafts with improved biocompatibility, durability, and handling characteristics.Minimally Invasive Procedures: The shift towards minimally invasive vascular procedures, such as endovascular stenting and angioplasty, has expanded the indications for vascular grafts, including complex lesions, tortuous anatomy, and high-risk patients.Growing Demand for Hemodialysis Access: The increasing prevalence of end-stage renal disease (ESRD) and the growing number of patients requiring hemodialysis access drive the demand for vascular grafts for arteriovenous fistula (AVF) and arteriovenous graft (AVG) creation.Regulatory Approvals and Reimbursement: Regulatory approvals for new vascular graft technologies and favorable reimbursement policies for vascular procedures support market growth and adoption by healthcare providers and patients.
Challenges and Opportunities:
Thrombosis and Graft Failure: Thrombosis, graft infection, and graft failure remain significant challenges in vascular surgery, necessitating ongoing research and innovation to improve graft patency, long-term durability, and clinical outcomes.Biocompatibility and Tissue Engineering: Enhancing the biocompatibility of vascular grafts, promoting tissue integration, and stimulating endothelialization are areas of active research in vascular tissue engineering, offering opportunities for developing next-generation graft materials and coatings.Patient-specific Solutions: Personalized medicine approaches, such as patient-specific graft design and tissue engineering, hold promise for optimizing graft performance, reducing complications, and improving patient outcomes in vascular surgery.Healthcare Infrastructure: Access to advanced vascular care, including surgical expertise, imaging technologies, and specialized facilities, varies across regions, presenting challenges and opportunities for market penetration and expansion in emerging markets.
Key Market Players:
The vascular graft market includes a diverse range of manufacturers, including multinational corporations, medical device companies, and specialty suppliers.Major players in the market include companies such as Medtronic plc, Terumo Corporation, Cook Medical Inc., B. Braun Melsungen AG, C. R. Bard, Inc. (acquired by BD), LeMaitre Vascular, Inc., and Getinge AB, among others.
Research and Development Initiatives:
Ongoing research efforts focus on developing novel graft materials, bioactive coatings, tissue-engineered constructs, and drug-eluting grafts to improve graft performance, reduce complications, and enhance long-term outcomes in vascular surgery.
Unhealthy habits such as excessive alcohol intake, smoking, and tobacco consumption along with inherited diseases or genetic defects are likely to promote the growth trends of the vascular graft market over the forecast period. Low compensation and high costs associated with the product across the emerging countries, however, is forecast to diminish the progression rate for vascular graft market in the coming decade.
Improved Healthcare & Medical Facilities To Augment Regional Growth
Regionally, North America has been leading the worldwide vascular graft market and is anticipated to continue on the dominant position in the years to come, states the vascular graft market study. The presence of a well-established medical and healthcare infrastructure and skilled healthcare professionals is the main factor behind the dominance of the North America vascular graft market. The high number of key market players being headquartered in North America is another significant factor that is supporting the expansion of this regional vascular graft market. In addition, massive funding of R& D and healthcare activities is likely to further proliferate the rate of development for vascular graft market.
Key Companies and & Market Share Insights
Partnerships, collaborations, mergers & acquisitions, and the development of new products are the key strategies adopted by key players operating in the market to gain a competitive edge in the market. For instance, in November 2019, Terumo Corporation announced the acquisition of Aortic Corporation. The acquisition aided the growth of the company’s vascular grafts business segment and contributed toward personalized aortic therapy.
The report also includes detailed profiles of end players such as -
Artegraft
B. Braun Melsungen
C.R. Bard
Cook Medical
CryoLife
Heart Medical Europe BV
LeMaitre Vascular
MAQUET Holding
Medtronic
Shanghai Suokang Medical Implants
Vascular Grafts Solutions and others
The global vascular graft market is segmented as follows:
By Product
Hemodialysis Access Graft
Endovascular Stent Graft
Peripheral vascular
Coronary Artery Bypass Graft
By Raw Material
Polyester
Polytetrafluoroethylene (PTFE)
Polyurethane
Biosynthetic
By End-User
Hospitals
Ambulatory Surgery Center
Others
By Region
North AmericaThe U.S.
EuropeUKFranceGermany
Asia PacificChinaJapanIndia
Latin AmericaBrazil
The Middle East and Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com
Comments
Post a Comment